My NCBI | Sign In
RSS Settings
  • Search: Litherland SA[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 21

    1.

    Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans.

    Haskell-Luevano C, Xiang Z, Wilczynski AM, Haskell KR, Andreasen AM, Litherland SA, Millard WJ, Pogozheva ID, Mosberg HI, Sorenson NB.

    Adv Exp Med Biol. 2009;611:509-10. No abstract available. PMID: 19400288 [PubMed - indexed for MEDLINE]Related articles

    2.

    Construction and characterization of melanocortin-2 and -4 receptor chimeras.

    Wilson KR, Proneth B, Luesch H, Litherland SA, Haskell-Luevano C.

    Adv Exp Med Biol. 2009;611:301-2. No abstract available. PMID: 19400202 [PubMed - indexed for MEDLINE]Related articles

    3.

    M-CSF and GM-CSF regulation of STAT5 activation and DNA binding in myeloid cell differentiation is disrupted in nonobese diabetic mice.

    Rumore-Maton B, Elf J, Belkin N, Stutevoss B, Seydel F, Garrigan E, Litherland SA.

    Clin Dev Immunol. 2008;2008:769795. Epub 2009 Jan 20.PMID: 19165346 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Immunopathogenic interaction of environmental triggers and genetic susceptibility in diabetes: is epigenetics the missing link?

    Litherland SA.

    Diabetes. 2008 Dec;57(12):3184-6. No abstract available. PMID: 19033405 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse.

    Haskell-Luevano C, Schaub JW, Andreasen A, Haskell KR, Moore MC, Koerper LM, Rouzaud F, Baker HV, Millard WJ, Walter G, Litherland SA, Xiang Z.

    FASEB J. 2009 Feb;23(2):642-55. Epub 2008 Oct 29.PMID: 18971258 [PubMed - indexed for MEDLINE]Related articles

    6.

    GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells.

    Seydel F, Garrigan E, Stutevoss B, Belkin N, Makadia B, Carter J, Shi JD, Davoodi-Semiromi A, McDuffie M, Litherland SA.

    J Autoimmun. 2008 Dec;31(4):377-84. Epub 2008 Oct 21.PMID: 18945591 [PubMed - indexed for MEDLINE]Related articles

    7.

    Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms.

    Xiang Z, Pogozheva ID, Sorenson NB, Wilczynski AM, Holder JR, Litherland SA, Millard WJ, Mosberg HI, Haskell-Luevano C.

    Biochemistry. 2007 Jul 17;46(28):8273-87. Epub 2007 Jun 23.PMID: 17590021 [PubMed - indexed for MEDLINE]Related articles

    8.

    Characterization of HKE2: an ancient antigen encoded in the major histocompatibility complex.

    Ostrov DA, Barnes CL, Smith LE, Binns S, Brusko TM, Brown AC, Quint PS, Litherland SA, Roopenian DC, Iczkowski KA.

    Tissue Antigens. 2007 Feb;69(2):181-8.PMID: 17257322 [PubMed - indexed for MEDLINE]Related articles

    9.

    Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.

    Murawski MR, Litherland SA, Clare-Salzler MJ, Davoodi-Semiromi A.

    Ann N Y Acad Sci. 2006 Oct;1079:198-204.PMID: 17130555 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.

    Xiang Z, Litherland SA, Sorensen NB, Proneth B, Wood MS, Shaw AM, Millard WJ, Haskell-Luevano C.

    Biochemistry. 2006 Jun 13;45(23):7277-88.PMID: 16752916 [PubMed - indexed for MEDLINE]Related articles

    11.

    Molecular mechanism of the constitutive activation of the L250Q human melanocortin-4 receptor polymorphism.

    Proneth B, Xiang Z, Pogozheva ID, Litherland SA, Gorbatyuk OS, Shaw AM, Millard WJ, Mosberg HI, Haskell-Luevano C.

    Chem Biol Drug Des. 2006 Mar;67(3):215-29.PMID: 16611215 [PubMed - indexed for MEDLINE]Related articles

    12.

    Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction.

    Litherland SA, Grebe KM, Belkin NS, Paek E, Elf J, Atkinson M, Morel L, Clare-Salzler MJ, McDuffie M.

    J Immunol. 2005 Oct 1;175(7):4561-5.PMID: 16177100 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Signal transduction activator of transcription 5 (STAT5) dysfunction in autoimmune monocytes and macrophages.

    Litherland SA, Xie TX, Grebe KM, Davoodi-Semiromi A, Elf J, Belkin NS, Moldawer LL, Clare-Salzler MJ.

    J Autoimmun. 2005 Jun;24(4):297-310. Epub 2005 Mar 23.PMID: 15927792 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Ultrasensitive detection of biomolecules with fluorescent dye-doped nanoparticles.

    Lian W, Litherland SA, Badrane H, Tan W, Wu D, Baker HV, Gulig PA, Lim DV, Jin S.

    Anal Biochem. 2004 Nov 1;334(1):135-44.PMID: 15464962 [PubMed - indexed for MEDLINE]Related articles

    15.

    In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow.

    Tang DQ, Cao LZ, Burkhardt BR, Xia CQ, Litherland SA, Atkinson MA, Yang LJ.

    Diabetes. 2004 Jul;53(7):1721-32.PMID: 15220196 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    IL10 resistant PGS2 expression in at-risk/Type 1 diabetic human monocytes.

    Litherland SA, Xie TX, Grebe KM, Li Y, Moldawer LL, Clare-Salzler MJ.

    J Autoimmun. 2004 May;22(3):227-33.PMID: 15041043 [PubMed - indexed for MEDLINE]Related articles

    17.

    Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset.

    Litherland SA, She JX, Schatz D, Fuller K, Hutson AD, Peng RH, Li Y, Grebe KM, Whittaker DS, Bahjat K, Hopkins D, Fang Q, Spies PD, North K, Wasserfall C, Cook R, Dennis MA, Crockett S, Sleasman J, Kocher J, Muir A, Silverstein J, Atkinson M, Clare-Salzler MJ.

    Pediatr Diabetes. 2003 Mar;4(1):10-8.PMID: 14655518 [PubMed - indexed for MEDLINE]Related articles

    18.

    CapG(-/-) mice have specific host defense defects that render them more susceptible than CapG(+/+) mice to Listeria monocytogenes infection but not to Salmonella enterica serovar Typhimurium infection.

    Parikh SS, Litherland SA, Clare-Salzler MJ, Li W, Gulig PA, Southwick FS.

    Infect Immun. 2003 Nov;71(11):6582-90.PMID: 14573680 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.

    Litherland SA, Xie XT, Hutson AD, Wasserfall C, Whittaker DS, She JX, Hofig A, Dennis MA, Fuller K, Cook R, Schatz D, Moldawer LL, Clare-Salzler MJ.

    J Clin Invest. 1999 Aug;104(4):515-23.PMID: 10449443 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Efficacy of the rat bioassay for the determination of biologically available vitamin B-6.

    Gregory JF 3rd, Litherland SA.

    J Nutr. 1986 Jan;116(1):87-97.PMID: 3944659 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Relative biological activity of nonphosphorylated vitamin B-6 compounds in the rat.

    Nguyen LB, Hiner ME, Litherland SA, Gregory JF 3rd.

    J Agric Food Chem. 1983 Nov-Dec;31(6):1282-7. No abstract available. PMID: 6655143 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    5 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity